GlassScriptPhysician profile
Brandy L Molbert
NPI 1679661615
$920.13
in general payments reported to CMS, 2019-2025
17 companies · $78.73 in 2025
The $78.73 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $316 · 2022: $348 · 2023: $77.37 · 2024: $99.90 · 2025: $78.73.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $256.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $256.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $283.76 | 2022 | |
| Getinge USA Sales, LLC | $103.85 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $99.99 | 2021 | |
| Stryker Corporation | $60.04 | 2023 | Axsos |
| Ferring Pharmaceuticals INC. | $52.35 | 2021-2022 | |
| E.R. Squibb & Sons, L.L.C. | $52.29 | 2024-2025 | Eliquis |
| Bioventus LLC | $47.44 | 2021-2022 | |
| Fidia Pharma USA INC. | $46.02 | 2021 | |
| Pfizer INC. | $33.18 | 2024 | |
| Boston Scientific Corporation | $25.52 | 2025 | Enroute Transcarotid Neuroprotection System |
| Aimmune Therapeutics, INC. | $19.29 | 2024 | |
| Merck Sharp & Dohme LLC | $19.10 | 2025 | Zerbaxa |
| Kowa Pharmaceuticals America, INC. | $18.53 | 2022 | |
| Kci USA, INC. | $17.33 | 2023 | Activ.A.C. |
| Janssen Pharmaceuticals, INC | $15.82 | 2024 | Xarelto |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $13.43 | 2024 | |
| Abbvie INC. | $12.19 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brandy Molbert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.